/PRNewswire/ apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine®, a pioneering.
HAMBURG, Germany, Dec. 5, 2022 /PRNewswire/ apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine, a pioneering